Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3Unknown 1Terminated 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 49Rectal Neoplasms 26Colonic Neoplasms 23Pancreatic Neoplasms 19Neoplasm Metastasis 17Neoplasms 13Stomach Neoplasms 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Esophageal Neoplasms 6Osteosarcoma 5Lymphoma, Non-Hodgkin 5Leukemia, Myeloid, Acute 5Burkitt Lymphoma 5Myelodysplastic Syndromes 4Gallbladder Neoplasms 4Adenocarcinoma Of Esophagus 4Triple Negative Breast Neoplasms 3Sarcoma 3Melanoma 3Lymphoma 3Lung Neoplasms 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Lymphocytic, Chronic, B-Cell 3Hematologic Neoplasms 3Cholangiocarcinoma 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Breast Neoplasms 3Bile Duct Neoplasms 3Somatostatinoma 2

Interventions

Irinotecan 3alectinib 1Leucovorin 1KRN-330 1Fluorouracil 1Cetuximab 1Bevacizumab 1Ascorbic Acid 1ABT-165 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Intestinal Neoplasms × Leucovorin × Clear all
NCT03368859 2021-02-09

A Study of ABT-165 Plus FOLFIRI vs Bevacizumab Plus FOLFIRI in Subjects With Metastatic Colorectal Cancer Previously Treated With Fluoropyrimidine, Oxaliplatin and Bevacizumab

AbbVie

Phase 2 Terminated
70 enrolled 12 charts
Gastrointestinal

Intestinal Neoplasms, Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡